2002
DOI: 10.1053/clon.2002.0065
|View full text |Cite
|
Sign up to set email alerts
|

Chemotherapy Associated Arterial Thrombosis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2003
2003
2020
2020

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(1 citation statement)
references
References 2 publications
0
1
0
Order By: Relevance
“…It is also reported in prospective trials that cisplatin has as significantly greater risk of inducing thromboembolic events when compared to other platinum-based chemotherapeutics [5] . There are cases reporting vasospasm and aortic thrombi with potentially fatal distal embolisation in patients undergoing chemotherapy, but AMAT is rare ( Table 2 ) [6] , [7] , [8] , [9] , [10] , [11] . However, it seems that the apparent contribution of cisplatin to arterial thrombosis seems underappreciated amongst clinicians.…”
Section: Discussionmentioning
confidence: 99%
“…It is also reported in prospective trials that cisplatin has as significantly greater risk of inducing thromboembolic events when compared to other platinum-based chemotherapeutics [5] . There are cases reporting vasospasm and aortic thrombi with potentially fatal distal embolisation in patients undergoing chemotherapy, but AMAT is rare ( Table 2 ) [6] , [7] , [8] , [9] , [10] , [11] . However, it seems that the apparent contribution of cisplatin to arterial thrombosis seems underappreciated amongst clinicians.…”
Section: Discussionmentioning
confidence: 99%